Enhanced dermatologic management
61186372NSC4015
Approved other active
Quick answer
Enhanced dermatologic management for NSCLC (Advanced Non-small Cell Lung Cancer) is a Approved program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- NSCLC (Advanced Non-small Cell Lung Cancer)
- Phase
- Approved
- Modality
- other
- Status
- active